Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial

David Kimberlin, Dwight Powell, William Gruber, Pamela Diaz, Ann Arvin, Mary Kumar, Richard Jacobs, Russell Van Dyke, Sandra Burchett, Seng Jaw Soong, Alfred Lakeman, Richard Whitley, C. Laughlin, A. Lakeman, S. J. Soong, D. Kimberlin, S. Stagno, R. Pass, A. Arvin, C. ProberJ. Bradley, S. Spector, L. Corey, G. Demmler, S. Burchett, S. Adler, J. Bale, Y. Bryson, T. Chonmaitree, P. Diaz, J. Gross, W. Gruber, R. Jacobs, H. Keyserling, J. Kinney, A. Kovacs, M. Kumar, S. Laudert, C. Leach, E. Leistikow, R. McKinney, C. Meissner, J. Modlin, D. Powell, M. Rathore, P. Reuman, J. Robinson, W. Vaudry, C. Sander, M. Shelton, M. De Sierra, L. Stanberry, S. Starr, R. Steele, G. Storch, R. Van Dyke, L. Weiner

    Research output: Contribution to journalArticlepeer-review

    131 Scopus citations

    Fingerprint

    Dive into the research topics of 'Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial'. Together they form a unique fingerprint.

    INIS

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases

    Medicine and Dentistry